PASINI, AUGUSTO
 Distribuzione geografica
Continente #
NA - Nord America 33.868
EU - Europa 2.841
AS - Asia 2.727
SA - Sud America 402
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 10
Totale 39.901
Nazione #
US - Stati Uniti d'America 33.776
SG - Singapore 1.224
CN - Cina 632
DE - Germania 477
UA - Ucraina 460
RU - Federazione Russa 346
BR - Brasile 326
IT - Italia 317
IE - Irlanda 275
SE - Svezia 238
VN - Vietnam 237
HK - Hong Kong 235
GB - Regno Unito 190
FR - Francia 181
FI - Finlandia 112
PL - Polonia 106
KR - Corea 92
JP - Giappone 75
IN - India 53
CA - Canada 45
TW - Taiwan 33
MX - Messico 32
BD - Bangladesh 28
BE - Belgio 26
NL - Olanda 25
CZ - Repubblica Ceca 23
AR - Argentina 21
TR - Turchia 19
ES - Italia 17
EC - Ecuador 15
IQ - Iraq 15
AT - Austria 13
CL - Cile 13
EU - Europa 13
CO - Colombia 12
IL - Israele 12
ZA - Sudafrica 12
ID - Indonesia 11
CH - Svizzera 9
AU - Australia 8
PK - Pakistan 8
PY - Paraguay 7
IR - Iran 6
MY - Malesia 6
PH - Filippine 6
EG - Egitto 5
KE - Kenya 5
MA - Marocco 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
LT - Lituania 4
SA - Arabia Saudita 4
VE - Venezuela 4
CR - Costa Rica 3
ET - Etiopia 3
HU - Ungheria 3
KZ - Kazakistan 3
NP - Nepal 3
RS - Serbia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GR - Grecia 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
GE - Georgia 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
VI - Stati Uniti Isole Vergini 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 39.901
Città #
Woodbridge 10.278
Wilmington 8.513
Houston 7.737
Fairfield 923
Ann Arbor 899
Singapore 736
Chandler 570
Ashburn 552
Jacksonville 421
Seattle 378
Cambridge 320
San Jose 310
Beijing 271
Dublin 269
Hong Kong 233
Medford 203
Dearborn 179
New York 175
Santa Clara 117
The Dalles 111
Lawrence 99
Ho Chi Minh City 81
Kraków 75
Los Angeles 74
Tokyo 64
Mülheim 63
Dallas 62
Rome 59
Council Bluffs 55
Menlo Park 50
Buffalo 49
San Diego 49
Hanoi 48
Moscow 46
Redwood City 46
Lauterbourg 44
Milan 43
Boardman 42
Munich 38
Zhengzhou 37
Falls Church 35
São Paulo 35
Taipei 32
Norwalk 30
Palo Alto 26
Mountain View 25
Brno 23
Brussels 23
San Mateo 22
Nanjing 21
London 19
Brooklyn 18
Chicago 18
Redondo Beach 18
Columbus 17
Orem 17
University Park 17
Frankfurt am Main 16
Guangzhou 16
Kunming 16
Rio de Janeiro 15
Warsaw 15
Chennai 14
Phoenix 14
Toronto 13
Denver 12
Hefei 12
Nuremberg 12
Stockholm 12
Atlanta 11
Detroit 11
Helsinki 11
Montreal 11
Nanchang 11
Verona 11
Washington 11
Brasília 10
Da Nang 10
Amsterdam 9
Catania 9
Istanbul 9
Poplar 9
Turku 9
Belo Horizonte 8
Boston 8
Haiphong 8
Mexico City 8
Nürnberg 8
Shanghai 8
Curitiba 7
Guayaquil 7
Hải Dương 7
Indiana 7
Jinan 7
Manchester 7
Porto Alegre 7
San Francisco 7
Auburn Hills 6
Biên Hòa 6
Campinas 6
Totale 35.146
Nome #
GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment 558
Association study of a promoter polymorphism of UFD1L gene with schizophrenia 521
Association between schizohprenia and UFD1L. A developmental gene mapped to chromosome 22 518
Alexithymia as related to sex, age, and educational level: Results of the Toronto Alexithymia Scale in 417 normal subjects 517
Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients 488
Human endogenous retroviruses and ADHD 487
Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: a case-control study 486
Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients. 479
Assessing attentional systems in children with Attention Deficit Hyperactivity Disorder 478
Association study between CAG trinucleotide repeats in the PCQAP gene (PC2 glutamine/Q-rich-associated protein) and schizophrenia 474
Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: A case-control study 471
5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo 468
Marked decrease of plasma neuroactive steroids during alcohol withdrawal 467
Detecting anxiety symptoms in children and youths with neurofibromatosis type I 466
Residential facilities for older people in Italy: a five-region survey 466
Assessment of depression in Alzheimer's disease: symptoms, syndrome, and computed tomography findings 465
Patients with deficit, nondeficit, and negative symptom schizophrenia: Do they differ during episodes of acute psychotic decompensation? 464
Neuroleptic treatments and overflow movements in schizophrenia: are they independent? 464
Fluoxetine decreases concentrations of 3 alpha,5 alpha-tetrahydrodeoxycorticosterone (THDOC) in major depression 463
Effects of antidepressant treatment on neuroactive steroids in major depression 460
Adhd and human endogenous retroviruses 460
Lack of potentiation of anticonvulsant effect by fluoxetine in drug-resistant epilepsy 457
Fluoxetine alone in the treatment of first episode anxious-depression: An open clinical trial 455
Asynchronicity of Organic and Psychiatric Symptoms in a Case of Sertraline Intoxication 449
Impairment in flexible regulation of speed and accuracy in children with ADHD 447
ALEXITHYMIA AS RELATED TO SEX, AGE, AND EDUCATIONAL-LEVEL - RESULTS OF THE TORONTO ALEXITHYMIA SCALE IN 417 NORMAL SUBJECTS 446
Typical and atypical antipsychotic use in aggressive children and adolescents: A systematic review [Uso degli antipsicotici tipici e atipici nel trattamento dell'aggressività nell'infanzia e nell'adolescenza: Revisione sistematica della letteratura] 446
Alexithymic features in stroke: Effects of laterality and gender 445
Neurosteroids as neuromodulators in the treatment of anxiety disorders 441
Neuroactive steroids in responders and nonresponders to sleep deprivation 440
Neurological soft signs are associated with attentional dysfunction in children with attention deficit hyperactivity disorder 440
Overflow movements and white matter abnormalities in ADHD 436
Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression. 432
Change blindness in children with ADHD: a selective impairment in visual search? 432
Dysfunctional personality traits in adolescence: effects on alerting, orienting and executive control of attention 431
Pathophysiology of NSS in ADHD 425
Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder preliminary results 424
Timing and clinical characteristics of topiramate-induced psychosis in a patient with epilepsy and tuberous sclerosis 423
Effects of fluoxetine on aggressive behavior of adult inpatients with mental retardation and epilepsy 423
Attention and executive functions profile in drug naive ADHD subtypes 422
Mutations of the Nogo-66 receptor (RTN4R) gene in schizophrenia 422
Anticonvulsant effect of intranigral fluoxetine 420
Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy in major depression 419
Overflow movements and white matter abnormalities in ADHD 418
Psychiatric symptoms in male cannabis users not using other illicit drugs 418
Increased neurosteroids synthesis after brain and spinal cord injury in rats 417
Controlling attention to gaze and arrows in attention deficit hyperactivity disorder 416
Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery 415
Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers 415
Negative symptoms and visual behavior in DSM-III-R prognostic subtypes of schizophreniform disorder 415
Planning deficit in children with neurofibromatosis type 1: a neurocognitive trait independent from attention-deficit hyperactivity disorder (ADHD)? 413
The neurobiology of attention deficit/hyperactivity disorder. 412
Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3 alpha-hydroxysteroid dehydrogenase activity 411
Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial 410
Ethological predictors of amitriptyline response in depressed outpatients 409
Prefrontal blood flow dysregulation in drug naive ADHD children without structural abnormalities 406
Marked decrease of plasma neuroactive steroids during alcohol withdrawa 405
Inhibition of return in response to eye gaze and peripheral cues in young people with Asperger's syndrome 404
Impaired reflexive orienting to social cues in attention deficit hyperactivity disorder 404
A Small Supernumerary Marker Derived from the Pericentromeric Region of Chromosome 5: Case Report and Delineation of Partial Trisomy 5p Phenotype 399
Reduced prefrontal cognitive activation associated with aggression in schizophrenia 398
Altered anandamide degradation in attention-deficit/hyperactivity disorder 397
The complex roles of neurosteroids in depression and anxiety disorders. 395
Panic induction with cholecystokinin-tetrapeptide (CCK-4) increases plasma concentrations of the neuroactive steroid 3 alpha, 5 alpha tetrahydrodeoxycorticosterone (3 alpha, 5 alpha-THDOC) in healthy volunteers 391
Marked decrease of plasma neuroactive steroids during alcohol withdrawal 390
Nonverbal behavior and alexithymic traits in normal subjects. Individual differences in encoding emotions 387
Paranoid/belligerence and neuroleptic dosage in newly admitted schizophrenic patients 384
Neuroactive steroids are not affected by panic induction with 50 μg cholecystokinin-tetrapeptide (CCK-4) in healthy volunteers [1] 383
Effects of combination treatment with mood stabilizers and mirtazapine on plasma concentrations of neuroactive steroids in depressed patients 382
Fluoxetine and seizures 380
Neurological soft signs, but not theory of mind and emotion recognition deficit distinguished children with ADHD from healthy control 380
Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders 378
Effects of fluoxetine, indomethacine and placebo on 3 alpha, 5 alpha tetrahydroprogesterone (THP) plasma levels in uncomplicated alcohol withdrawal. 378
Motor examination in children with Attention-deficit/hyperactivity Disorder and Asperger Syndrome 377
Dopamine dysfunction in 22q11 deletion syndrome: possible cause of motor symptoms 377
Is it confirmed the presence of neurological soft signs in children with Neurofibromatosis type 1? 371
Dose-dependent effect of risperidone treatment in a case of 22q13.3 deletion syndrome 370
Changes in CCK-4 induced panic after treatment with the GABA-reuptake inhibitor tiagabine are associated with an increase in 3α,5α-tetrahydrodeoxycorticosterone concentrations 368
Visual search and emotion: how children with autism spectrum disorders scan emotional scenes 367
Comorbidity of ADHD and High-functioning Autism: A Pilot Study on the Utility of the Overflow Movements Measure 366
Pathophysiology of NSS in ADHD 364
Ethological assessment of the DSM-III subtyping of unipolar depression 360
The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin 359
Explicit incestuous motifs and emotional crises in psychosomatic patients 354
Neurosteroids in developmental disorders 353
First evidence of HERV-H transcriptional activity reduction after methylphenidate treatment in a young boy with ADHD 351
[Executive function deficits in ADHD and Asperger syndrome] 351
Neuroactive steroids as modulators of depression and anxiety 349
5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin 342
LE ALLUCINAZIONI 335
Influence of sleep deprivation major depression on neuroactive steroids in major depression 322
Non-verbal behaviour deficits in schizophrenia: an ethological study of drug-free patients 311
Il Delirio 297
I retrovirus endogeni nella sindrome da deficit di attenzione e iperattività (ADHD). 292
Scientific Evidence for the Evaluation of Neurological Soft Signs as Atypical Neurodevelopment Markers in Childhood Neuropsychiatric Disorders 258
The decrease in human endogenous retrovirus-H activity runs in parallel with improvement in ADHD symptoms in patients undergoing methylphenidate therapy 244
Antipsychotics do not influence neurological soft signs in children and adolescents at ultra-high risk for psychosis: A pilot study 173
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 160
Rett syndrome in males: The different clinical course in two brothers with the same microduplication MECP2 Xq28 112
The Effects of Lock-down 2020 on the Behaviour and Mood of Children Aged Three to Six in Italy 52
Totale 40.040
Categoria #
all - tutte 81.385
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.385


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021287 0 0 0 0 0 0 0 0 0 0 201 86
2021/20221.077 44 124 97 64 25 124 43 53 76 95 62 270
2022/20231.453 127 91 36 217 144 338 116 98 128 2 125 31
2023/2024510 62 27 43 11 45 176 49 6 4 8 7 72
2024/20251.791 100 458 262 122 50 83 87 110 162 127 132 98
2025/20263.186 359 162 395 265 349 105 351 426 439 293 42 0
Totale 40.040